HOUSTON – The Houston Methodist Hospital is now administering the FDA emergency use authorization drug, bamlanivimab. There are three sites where the hospital offers monoclonal antibody infusions: Houston Methodist Hospital at the Texas Medical Center, Houston Methodist Sugar Land and Houston Methodist Continuing Care Facility near the West campus in Katy. Since the hospital system started this therapy on Friday, they said 50 patients have been treated. Sandy Zeluff said she was one of the first patients to receive this treatment. After her symptoms were getting progressively worse last week, she says she made a recovery within a day of infusion.